Skip to main content
. 2016 May 16;2016:4108490. doi: 10.1155/2016/4108490

Figure 2.

Figure 2

Graph showing changes in the number of antiglaucomatous medications applied from baseline to 12 months after treatment. At every follow-up visit, compared to baseline, the number of antiglaucomatous medications undertaken significantly reduced (P < 0.01).